BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9100602)

  • 1. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K; Tamura Y; Yoshida S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
    Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C; Burgemeister A; Lüthke K; Born J; Fehm HL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1151-7. PubMed ID: 9543132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in plasma ACTH and cortisol after hypertonic saline infusion in patients with central diabetes insipidus.
    Itagaki E; Ozawa S; Yamaguchi S; Ushikawa K; Tashiro T; Katahira H; Takizawa M; Yoshimoto K; Murakawa S; Ishida H
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5749-54. PubMed ID: 11739434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants.
    Ng PC; Wong GW; Lam CW; Lee CH; Wong MY; Fok TF; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Mar; 82(3):797-9. PubMed ID: 9062485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man.
    Rittmaster RS; Cutler GB; Gold PW; Brandon DD; Tomai T; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Feb; 64(2):371-6. PubMed ID: 3025246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy.
    Florkowski CM; Crozier IG; Nightingale S; Evans MJ; Ellis MJ; Joyce P; Donald RA
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):163-8. PubMed ID: 8849570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
    Kellner M; Wiedemann K; Holsboer F
    Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamus-pituitary-adrenal axis in central diabetes insipidus: ACTH and cortisol responsiveness to CRH administration.
    Pivonello R; Faggiano A; Filippella M; Di Somma C; De Martino MC; Gaccione M; Lombardi G; Colao A
    J Endocrinol Invest; 2002 Dec; 25(11):932-7. PubMed ID: 12553551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T; Tanaka K; Kumagae M; Itoh S; Kogure M; Hasegawa M; Horiuchi T; Morio K; Takeda F; Ubukata E
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F; Velut JG; Guillaume V; Sauze N; Orsoni JC; Gaillard RC; Oliver CC
    Neuroendocrinology; 1999 May; 69(5):352-9. PubMed ID: 10343176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.
    Mortola JF; Rasmussen DD; Yen SS
    J Clin Endocrinol Metab; 1989 Mar; 68(3):517-22. PubMed ID: 2537336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.